Donepezil hydrochloride is areversible inhibitor of the enzyme acetylcholinesterase. It is indicated forthe treatment of dementia of the Alzheimers type.
The global Donepezil Hydrochloride API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Donepezil Hydrochloride API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Donepezil Hydrochloride API.
Report Scope
The Donepezil Hydrochloride API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Donepezil Hydrochloride API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Donepezil Hydrochloride API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gonane Pharma
Wavelength Pharmaceuticals
Dr. Reddy's Laboratories
Rumit Group
Summit Pharmaceuticals
Teva API
Zhejiang Huahai Pharmaceutical
Zhejiang Hisun Pharmaceutical
Sun Pharmaceutical Industries
Wockhardt
Piramal Enterprises
Ralington pharma
Unichem Laboratories
Neuland Laboratories
Vasudha Pharma Chem
Perrigo API
USV Private
Torrent Pharmaceuticals
RANBAXY LABORATORIES
Hetero Drugs
Jubilant Generics
Megafine Pharma
Segment by Type
Purity 98%
Purity > 98%
Segment by Application
Tablet Products
Capsule Products
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Donepezil Hydrochloride API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Donepezil Hydrochloride API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Donepezil Hydrochloride API Market Overview
1.1 Product Overview and Scope of Donepezil Hydrochloride API
1.2 Donepezil Hydrochloride API Segment by Type
1.2.1 Global Donepezil Hydrochloride API Market Value Comparison by Type (2024-2030)
1.2.2 Purity 98%
1.2.3 Purity > 98%
1.3 Donepezil Hydrochloride API Segment by Application
1.3.1 Global Donepezil Hydrochloride API Market Value by Application: (2024-2030)
1.3.2 Tablet Products
1.3.3 Capsule Products
1.3.4 Others
1.4 Global Donepezil Hydrochloride API Market Size Estimates and Forecasts
1.4.1 Global Donepezil Hydrochloride API Revenue 2019-2030
1.4.2 Global Donepezil Hydrochloride API Sales 2019-2030
1.4.3 Global Donepezil Hydrochloride API Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Donepezil Hydrochloride API Market Competition by Manufacturers
2.1 Global Donepezil Hydrochloride API Sales Market Share by Manufacturers (2019-2024)
2.2 Global Donepezil Hydrochloride API Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Donepezil Hydrochloride API Average Price by Manufacturers (2019-2024)
2.4 Global Donepezil Hydrochloride API Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Donepezil Hydrochloride API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Donepezil Hydrochloride API, Product Type & Application
2.7 Donepezil Hydrochloride API Market Competitive Situation and Trends
2.7.1 Donepezil Hydrochloride API Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Donepezil Hydrochloride API Players Market Share by Revenue
2.7.3 Global Donepezil Hydrochloride API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Donepezil Hydrochloride API Retrospective Market Scenario by Region
3.1 Global Donepezil Hydrochloride API Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Donepezil Hydrochloride API Global Donepezil Hydrochloride API Sales by Region: 2019-2030
3.2.1 Global Donepezil Hydrochloride API Sales by Region: 2019-2024
3.2.2 Global Donepezil Hydrochloride API Sales by Region: 2025-2030
3.3 Global Donepezil Hydrochloride API Global Donepezil Hydrochloride API Revenue by Region: 2019-2030
3.3.1 Global Donepezil Hydrochloride API Revenue by Region: 2019-2024
3.3.2 Global Donepezil Hydrochloride API Revenue by Region: 2025-2030
3.4 North America Donepezil Hydrochloride API Market Facts & Figures by Country
3.4.1 North America Donepezil Hydrochloride API Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Donepezil Hydrochloride API Sales by Country (2019-2030)
3.4.3 North America Donepezil Hydrochloride API Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Donepezil Hydrochloride API Market Facts & Figures by Country
3.5.1 Europe Donepezil Hydrochloride API Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Donepezil Hydrochloride API Sales by Country (2019-2030)
3.5.3 Europe Donepezil Hydrochloride API Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Donepezil Hydrochloride API Market Facts & Figures by Country
3.6.1 Asia Pacific Donepezil Hydrochloride API Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Donepezil Hydrochloride API Sales by Country (2019-2030)
3.6.3 Asia Pacific Donepezil Hydrochloride API Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Donepezil Hydrochloride API Market Facts & Figures by Country
3.7.1 Latin America Donepezil Hydrochloride API Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Donepezil Hydrochloride API Sales by Country (2019-2030)
3.7.3 Latin America Donepezil Hydrochloride API Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Donepezil Hydrochloride API Market Facts & Figures by Country
3.8.1 Middle East and Africa Donepezil Hydrochloride API Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Donepezil Hydrochloride API Sales by Country (2019-2030)
3.8.3 Middle East and Africa Donepezil Hydrochloride API Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Donepezil Hydrochloride API Sales by Type (2019-2030)
4.1.1 Global Donepezil Hydrochloride API Sales by Type (2019-2024)
4.1.2 Global Donepezil Hydrochloride API Sales by Type (2025-2030)
4.1.3 Global Donepezil Hydrochloride API Sales Market Share by Type (2019-2030)
4.2 Global Donepezil Hydrochloride API Revenue by Type (2019-2030)
4.2.1 Global Donepezil Hydrochloride API Revenue by Type (2019-2024)
4.2.2 Global Donepezil Hydrochloride API Revenue by Type (2025-2030)
4.2.3 Global Donepezil Hydrochloride API Revenue Market Share by Type (2019-2030)
4.3 Global Donepezil Hydrochloride API Price by Type (2019-2030)
5 Segment by Application
5.1 Global Donepezil Hydrochloride API Sales by Application (2019-2030)
5.1.1 Global Donepezil Hydrochloride API Sales by Application (2019-2024)
5.1.2 Global Donepezil Hydrochloride API Sales by Application (2025-2030)
5.1.3 Global Donepezil Hydrochloride API Sales Market Share by Application (2019-2030)
5.2 Global Donepezil Hydrochloride API Revenue by Application (2019-2030)
5.2.1 Global Donepezil Hydrochloride API Revenue by Application (2019-2024)
5.2.2 Global Donepezil Hydrochloride API Revenue by Application (2025-2030)
5.2.3 Global Donepezil Hydrochloride API Revenue Market Share by Application (2019-2030)
5.3 Global Donepezil Hydrochloride API Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Gonane Pharma
6.1.1 Gonane Pharma Corporation Information
6.1.2 Gonane Pharma Description and Business Overview
6.1.3 Gonane Pharma Donepezil Hydrochloride API Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Gonane Pharma Donepezil Hydrochloride API Product Portfolio
6.1.5 Gonane Pharma Recent Developments/Updates
6.2 Wavelength Pharmaceuticals
6.2.1 Wavelength Pharmaceuticals Corporation Information
6.2.2 Wavelength Pharmaceuticals Description and Business Overview
6.2.3 Wavelength Pharmaceuticals Donepezil Hydrochloride API Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Wavelength Pharmaceuticals Donepezil Hydrochloride API Product Portfolio
6.2.5 Wavelength Pharmaceuticals Recent Developments/Updates
6.3 Dr. Reddy's Laboratories
6.3.1 Dr. Reddy's Laboratories Corporation Information
6.3.2 Dr. Reddy's Laboratories Description and Business Overview
6.3.3 Dr. Reddy's Laboratories Donepezil Hydrochloride API Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Dr. Reddy's Laboratories Donepezil Hydrochloride API Product Portfolio
6.3.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.4 Rumit Group
6.4.1 Rumit Group Corporation Information
6.4.2 Rumit Group Description and Business Overview
6.4.3 Rumit Group Donepezil Hydrochloride API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Rumit Group Donepezil Hydrochloride API Product Portfolio
6.4.5 Rumit Group Recent Developments/Updates
6.5 Summit Pharmaceuticals
6.5.1 Summit Pharmaceuticals Corporation Information
6.5.2 Summit Pharmaceuticals Description and Business Overview
6.5.3 Summit Pharmaceuticals Donepezil Hydrochloride API Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Summit Pharmaceuticals Donepezil Hydrochloride API Product Portfolio
6.5.5 Summit Pharmaceuticals Recent Developments/Updates
6.6 Teva API
6.6.1 Teva API Corporation Information
6.6.2 Teva API Description and Business Overview
6.6.3 Teva API Donepezil Hydrochloride API Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva API Donepezil Hydrochloride API Product Portfolio
6.6.5 Teva API Recent Developments/Updates
6.7 Zhejiang Huahai Pharmaceutical
6.6.1 Zhejiang Huahai Pharmaceutical Corporation Information
6.6.2 Zhejiang Huahai Pharmaceutical Description and Business Overview
6.6.3 Zhejiang Huahai Pharmaceutical Donepezil Hydrochloride API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zhejiang Huahai Pharmaceutical Donepezil Hydrochloride API Product Portfolio
6.7.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
6.8 Zhejiang Hisun Pharmaceutical
6.8.1 Zhejiang Hisun Pharmaceutical Corporation Information
6.8.2 Zhejiang Hisun Pharmaceutical Description and Business Overview
6.8.3 Zhejiang Hisun Pharmaceutical Donepezil Hydrochloride API Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Zhejiang Hisun Pharmaceutical Donepezil Hydrochloride API Product Portfolio
6.8.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
6.9 Sun Pharmaceutical Industries
6.9.1 Sun Pharmaceutical Industries Corporation Information
6.9.2 Sun Pharmaceutical Industries Description and Business Overview
6.9.3 Sun Pharmaceutical Industries Donepezil Hydrochloride API Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Sun Pharmaceutical Industries Donepezil Hydrochloride API Product Portfolio
6.9.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.10 Wockhardt
6.10.1 Wockhardt Corporation Information
6.10.2 Wockhardt Description and Business Overview
6.10.3 Wockhardt Donepezil Hydrochloride API Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Wockhardt Donepezil Hydrochloride API Product Portfolio
6.10.5 Wockhardt Recent Developments/Updates
6.11 Piramal Enterprises
6.11.1 Piramal Enterprises Corporation Information
6.11.2 Piramal Enterprises Donepezil Hydrochloride API Description and Business Overview
6.11.3 Piramal Enterprises Donepezil Hydrochloride API Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Piramal Enterprises Donepezil Hydrochloride API Product Portfolio
6.11.5 Piramal Enterprises Recent Developments/Updates
6.12 Ralington pharma
6.12.1 Ralington pharma Corporation Information
6.12.2 Ralington pharma Donepezil Hydrochloride API Description and Business Overview
6.12.3 Ralington pharma Donepezil Hydrochloride API Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Ralington pharma Donepezil Hydrochloride API Product Portfolio
6.12.5 Ralington pharma Recent Developments/Updates
6.13 Unichem Laboratories
6.13.1 Unichem Laboratories Corporation Information
6.13.2 Unichem Laboratories Donepezil Hydrochloride API Description and Business Overview
6.13.3 Unichem Laboratories Donepezil Hydrochloride API Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Unichem Laboratories Donepezil Hydrochloride API Product Portfolio
6.13.5 Unichem Laboratories Recent Developments/Updates
6.14 Neuland Laboratories
6.14.1 Neuland Laboratories Corporation Information
6.14.2 Neuland Laboratories Donepezil Hydrochloride API Description and Business Overview
6.14.3 Neuland Laboratories Donepezil Hydrochloride API Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Neuland Laboratories Donepezil Hydrochloride API Product Portfolio
6.14.5 Neuland Laboratories Recent Developments/Updates
6.15 Vasudha Pharma Chem
6.15.1 Vasudha Pharma Chem Corporation Information
6.15.2 Vasudha Pharma Chem Donepezil Hydrochloride API Description and Business Overview
6.15.3 Vasudha Pharma Chem Donepezil Hydrochloride API Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Vasudha Pharma Chem Donepezil Hydrochloride API Product Portfolio
6.15.5 Vasudha Pharma Chem Recent Developments/Updates
6.16 Perrigo API
6.16.1 Perrigo API Corporation Information
6.16.2 Perrigo API Donepezil Hydrochloride API Description and Business Overview
6.16.3 Perrigo API Donepezil Hydrochloride API Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Perrigo API Donepezil Hydrochloride API Product Portfolio
6.16.5 Perrigo API Recent Developments/Updates
6.17 USV Private
6.17.1 USV Private Corporation Information
6.17.2 USV Private Donepezil Hydrochloride API Description and Business Overview
6.17.3 USV Private Donepezil Hydrochloride API Sales, Revenue and Gross Margin (2019-2024)
6.17.4 USV Private Donepezil Hydrochloride API Product Portfolio
6.17.5 USV Private Recent Developments/Updates
6.18 Torrent Pharmaceuticals
6.18.1 Torrent Pharmaceuticals Corporation Information
6.18.2 Torrent Pharmaceuticals Donepezil Hydrochloride API Description and Business Overview
6.18.3 Torrent Pharmaceuticals Donepezil Hydrochloride API Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Torrent Pharmaceuticals Donepezil Hydrochloride API Product Portfolio
6.18.5 Torrent Pharmaceuticals Recent Developments/Updates
6.19 RANBAXY LABORATORIES
6.19.1 RANBAXY LABORATORIES Corporation Information
6.19.2 RANBAXY LABORATORIES Donepezil Hydrochloride API Description and Business Overview
6.19.3 RANBAXY LABORATORIES Donepezil Hydrochloride API Sales, Revenue and Gross Margin (2019-2024)
6.19.4 RANBAXY LABORATORIES Donepezil Hydrochloride API Product Portfolio
6.19.5 RANBAXY LABORATORIES Recent Developments/Updates
6.20 Hetero Drugs
6.20.1 Hetero Drugs Corporation Information
6.20.2 Hetero Drugs Donepezil Hydrochloride API Description and Business Overview
6.20.3 Hetero Drugs Donepezil Hydrochloride API Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Hetero Drugs Donepezil Hydrochloride API Product Portfolio
6.20.5 Hetero Drugs Recent Developments/Updates
6.21 Jubilant Generics
6.21.1 Jubilant Generics Corporation Information
6.21.2 Jubilant Generics Donepezil Hydrochloride API Description and Business Overview
6.21.3 Jubilant Generics Donepezil Hydrochloride API Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Jubilant Generics Donepezil Hydrochloride API Product Portfolio
6.21.5 Jubilant Generics Recent Developments/Updates
6.22 Megafine Pharma
6.22.1 Megafine Pharma Corporation Information
6.22.2 Megafine Pharma Donepezil Hydrochloride API Description and Business Overview
6.22.3 Megafine Pharma Donepezil Hydrochloride API Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Megafine Pharma Donepezil Hydrochloride API Product Portfolio
6.22.5 Megafine Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Donepezil Hydrochloride API Industry Chain Analysis
7.2 Donepezil Hydrochloride API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Donepezil Hydrochloride API Production Mode & Process
7.4 Donepezil Hydrochloride API Sales and Marketing
7.4.1 Donepezil Hydrochloride API Sales Channels
7.4.2 Donepezil Hydrochloride API Distributors
7.5 Donepezil Hydrochloride API Customers
8 Donepezil Hydrochloride API Market Dynamics
8.1 Donepezil Hydrochloride API Industry Trends
8.2 Donepezil Hydrochloride API Market Drivers
8.3 Donepezil Hydrochloride API Market Challenges
8.4 Donepezil Hydrochloride API Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Gonane Pharma
Wavelength Pharmaceuticals
Dr. Reddy's Laboratories
Rumit Group
Summit Pharmaceuticals
Teva API
Zhejiang Huahai Pharmaceutical
Zhejiang Hisun Pharmaceutical
Sun Pharmaceutical Industries
Wockhardt
Piramal Enterprises
Ralington pharma
Unichem Laboratories
Neuland Laboratories
Vasudha Pharma Chem
Perrigo API
USV Private
Torrent Pharmaceuticals
RANBAXY LABORATORIES
Hetero Drugs
Jubilant Generics
Megafine Pharma
听
听
*If Applicable.